Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Lukadin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Insmed Presents Phase 3B ENCORE Data for ARIKAYCE at ATS 2026
    Insmed Presents Phase 3B ENCORE Data for ARIKAYCE at ATS 2026

    04 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/insmed-to-present-data-across-its-respiratory-portfolio-including-late-breaking-arikayce-results-from-phase-3b-encore-study-at-the-american-thoracic-society-international-conference-2026-302760845.html

    PR NEWSWIRE
    04 May 2026
    Share Share
    Insmed Plots Key Expansion For Arikayce On New Data
    Insmed Plots Key Expansion For Arikayce On New Data

    23 Mar 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/trial-results-set-insmeds-arikayce-significant-label-expansion

    FIERCE PHARMA
    23 Mar 2026
    Share Share
    Insmed Releases 2025 Financial Results & Business Update
    Insmed Releases 2025 Financial Results & Business Update

    19 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/insmed-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-business-update-302691904.html

    PR NEWSWIRE
    19 Feb 2026
    Share Share
    Insmed Reports Q3 2024 Results and Business Update
    Insmed Reports Q3 2024 Results and Business Update

    31 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/insmed-reports-third-quarter-2024-financial-results-and-provides-business-update-302292334.html

    PR NEWSWIRE
    31 Oct 2024
    Share Share
    Insmed Reports Q2 2024 Results And Provides Business Update
    Insmed Reports Q2 2024 Results And Provides Business Update

    08 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/insmed-reports-second-quarter-2024-financial-results-and-provides-business-update-302217294.html

    PR NEWSWIRE
    08 Aug 2024
    Share Share
    Insmed Presents ARIKAYCE NTM PRO, Microbiology Data At ATS
    Insmed Presents ARIKAYCE NTM PRO, Microbiology Data At ATS

    20 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/insmed-presents-positive-patient-reported-outcomes-and-microbiologic-data-from-phase-3-arise-study-of-arikayce-amikacin-liposome-inhalation-suspension-in-patients-with-ntm-lung-disease-caused-by-mac-at-american-thoracic-society-302150522.html

    PR NEWSWIRE
    20 May 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.